Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.
Saved in:
| Title: | Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis. |
|---|---|
| Authors: | Zhu X; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., John AJ; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Kim S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Ding E; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Saleh A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Marín-Goñi I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Jomaa A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Gao H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wai CM; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Moon I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Coombes BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A., Kerr TM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Suto N; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Biernacka JM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Karpyak VM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Li H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 May 16. Date of Electronic Publication: 2025 May 16. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40463052 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhu+X%22">Zhu X</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22John+AJ%22">John AJ</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Ding+E%22">Ding E</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Saleh+A%22">Saleh A</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Marín-Goñi+I%22">Marín-Goñi I</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Jomaa+A%22">Jomaa A</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Gao+H%22">Gao H</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Wai+CM%22">Wai CM</searchLink>; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Moon+I%22">Moon I</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Coombes+BJ%22">Coombes BJ</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Kerr+TM%22">Kerr TM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Suto+N%22">Suto N</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Frye+MA%22">Frye MA</searchLink>; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Biernacka+JM%22">Biernacka JM</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Karpyak+VM%22">Karpyak VM</searchLink>; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Weinshilboum+RM%22">Weinshilboum RM</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2025 May 16. <i>Date of Electronic Publication: </i>2025 May 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40463052 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2025.05.15.654319 Languages: – Code: eng Text: English Titles: – TitleFull: Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhu X – PersonEntity: Name: NameFull: John AJ – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Kim S – PersonEntity: Name: NameFull: Ding E – PersonEntity: Name: NameFull: Saleh A – PersonEntity: Name: NameFull: Marín-Goñi I – PersonEntity: Name: NameFull: Jomaa A – PersonEntity: Name: NameFull: Gao H – PersonEntity: Name: NameFull: Wai CM – PersonEntity: Name: NameFull: Moon I – PersonEntity: Name: NameFull: Coombes BJ – PersonEntity: Name: NameFull: Kerr TM – PersonEntity: Name: NameFull: Suto N – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Frye MA – PersonEntity: Name: NameFull: Biernacka JM – PersonEntity: Name: NameFull: Karpyak VM – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Weinshilboum RM – PersonEntity: Name: NameFull: Liu D IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 05 Text: 2025 May 16 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |